One of the founding principles of Woodley BioReg was to improve the regulatory infrastructure to make medicines effective, safe, and of the same quality for all patients around the world and especially in developing nations.
This is reflected in the pro-bono work carried out in S.E. Asia, working with NGOs, universities, and local companies to educate and improve their understanding of compliance, cGMP, quality systems, and regulatory management of API and pharmaceutical manufacture.